Skip to main content

Amylyx Pharmaceuticals, Inc.

AMLX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001658551

In the last 90 days, Amylyx Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 206 institutions reported holding it in 13F filings for Q2 2026, worth $2.07B in total; no superinvestor holds it.

Politicians who traded AMLX

Since 2020, newest trade first. Shares and options by default, including trades reported under an earlier ticker.

Trades
1
Filings
1
Politicians
1
Buys / sells
1 / 0
Estimated volume
$8.00K
Sum of range midpoints
Politicians who traded AMLX
PoliticianTradesBuys / sellsEst. volumeLast tradedLast filed
Chris Jacobs House · NY
11 / 0$8.00KOct 12, 2022Nov 16, 2022

Trades

Reported trades in Amylyx Pharmaceuticals, Inc., newest filings first.

Politician trades
PoliticianAssetTypeOwnerTradedFiledDelayAmountSource
Chris Jacobs House · NY
AMLXAmylyx Pharmaceuticals, Inc.BuySelfOct 12, 2022Nov 16, 202235 days$1K-$15KFiling

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report. Profiles, committees and photos: the unitedstates project (public domain). District maps: U.S. Census Bureau.